logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Nurix Therapeutics, Inc. posts $12.68 million revenue in quarter ended Feb 28, 2023

By USInMinutes - Apr 13, 2023, 08:20 PM ET
Last Updated - Jul 18, 2023, 03:57 PM EDT
Nurix Therapeutics, Inc. posts $12.68 million revenue in quarter ended Feb 28, 2023

Key fundamental financials
  • loss of $40.73 million
  • Revenue of $12.68 million

Nurix Therapeutics, Inc. [NRIX] has reported $40.73 million loss for the fiscal quarter ending Feb 28, 2023.

Revenue for the quarter was $12.68 million with operating income of $42.95 million.

The Sanfrancisco, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $274.05 million.

Also read:

This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415